CVS expects to close $8 bln Signify deal this week

CVS

CVS expects to close $8 bln Signify deal this week

March 27 (Reuters) – CVS Health Corp (CVS.N) said on Monday it expects to complete its acquisition of healthcare services company Signify Health (SGFY.N) this week, subject to certain conditions, potentially ending months of antitrust scrutiny on the $8 billion deal.

CVS’ potential acquisitions of two healthcare service providers Signify and Oak Street Health (OSH.N), along with other such deals, have been facing increasing scrutiny over their impact on cost of healthcare in the United States.

Earlier this month, U.S. Senator Elizabeth Warren urged the U.S. Federal Trade Commission to review healthcare conglomerate CVS’ $9.5-billion acquisition of Oak Street as well as other merger deals in the sector.

Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli

Our Standards: The Thomson Reuters Trust Principles.

Source: Reuters

 

/by
You might also like
Moderna, COVID-19 vaccineModerna expects to price its COVID vaccine at about $130 in the US
Bristol Myers must face $6.4 bln lawsuit over delayed cancer drug
Federal Trade Commission buildingAmgen-Horizon merger clearance a setback to FTC’s antitrust enforcement plans
Novo Nordisk flagNovo Nordisk contracts South Africa’s Aspen to produce insulin for African nations
Eli LillyEli Lilly’s nationwide insulin pricing settlement called off
CVS HealthSandoz’s biosimilar skyrockets after CVS removes AbbVie’s Humira from formularies
MerckReport: Merck in advanced talks to acquire Seagen for $40B
WegovyObesity drug Wegovy’s popularity has US employers rethinking insurance coverage